Jens Benn Sørensen
Clinical Associate Professor
- 2024
- Published
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial
Haakensen, V. D., Öjlert, Å. K., Thunold, S., Farooqi, S., Nowak, A. K., Chin, W. L., Grundberg, O., Szejniuk, W. M., Cedres, S., Sørensen, Jens Benn, Dalen, T. S., Lund-Iversen, M., Bjaanæs, M. & Helland, Å., 2024, In: European Journal of Cancer. 202, 6 p., 113973.Research output: Contribution to journal › Journal article › Research › peer-review
- 2023
- Published
Artificial Intelligence for Automated DWI/FLAIR Mismatch Assessment on Magnetic Resonance Imaging in Stroke: A Systematic Review
Offersen, C. M., Sørensen, Jens Benn, Sheng, K., Carlsen, Jonathan Frederik, Langkilde, Annika Reynberg, Pai, A., Truelsen, Thomas Clement & Nielsen, Michael Bachmann, 2023, In: Diagnostics. 13, 12, 15 p., 2111.Research output: Contribution to journal › Review › Research › peer-review
- Published
Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?
Urbanska, E. M., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2023, In: Journal of Thoracic Oncology. 18, 3, p. e28-e29Research output: Contribution to journal › Letter › Research › peer-review
- Published
New pathogenic germline variants identified in mesothelioma
Belcaid, L., Bertelsen, B., Wadt, Karin Anna Wallentin, Tuxen, I., Spanggaard, I., Højgaard, M., Sørensen, Jens Benn, Ravn, J., Lassen, Ulrik Niels, Nielsen, Finn Cilius, Rohrberg, K. & Westmose Yde, C., 2023, In: Lung Cancer. 179, 8 p., 107172.Research output: Contribution to journal › Review › Research › peer-review
- Published
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC
Urbanska, E. M., Grauslund, M., Koffeldt, P. R., Truelsen, S. L. B., Löfgren, J. O., Costa, J. C., Melchior, L. C., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2023, In: International Journal of Molecular Sciences. 24, 17, 25 p., 13077.Research output: Contribution to journal › Journal article › Research › peer-review
- 2022
- Published
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Mouritzen, M. T., Junker, K. F., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L. & 7 others, , 2022, In: Acta Oncologica. 61, 4, p. 409-416Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non–Small-Cell Lung Cancer
Urbanska, E. M., Sørensen, Jens Benn, Melchior, L. C., Costa, J. C. & Santoni Rugiu, Eric, 2022, In: JCO Precision Oncology. 6, 6, 6 p., e2200040.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015): SCAN-LEAF study
Sørensen, Jens Benn, Horvat, P., Rosenlund, M., Kejs, A. M., Patel, D., Juarez-Garcia, A., Lacoin, L., Daumont, M. J., Penrod, J. R., O'donnell, J. C., Brustugun, O. T. & Ekman, S., 2022, In: Future Oncology. 18, 2, p. 205-214 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2021
- Published
Correlation of MET-receptor overexpression with MET gene amplification and patient outcome in malignant mesothelioma
Santoni Rugiu, Eric, Lü, M. J. S., Jakobsen, J. N., Melchior, L. C., Ravn, J. & Sørensen, Jens Benn, 2021, In: International Journal of Molecular Sciences. 22, 23, 20 p., 12868.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery
Urbanska, E. M., Santoni Rugiu, Eric, Melchior, L. C., Carlsen, Jonathan Frederik & Sørensen, Jens Benn, 2021, In: Clinical Lung Cancer. 22, 4, p. e528-e532 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study
Eide, I. J. Z., Grut, H., Helland, Å., Ekman, S., Sørensen, Jens Benn, Hansen, K. H., Grønberg, B. H., Cicenas, S., Koivunen, J. P., Mellemgaard, A. & Brustugun, O. T., 2021, In: Acta Oncologica. 60, 12, p. 1565-1571 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—real world efficacy
Mouritzen, M. T., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A. C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L., Frary, J. M. C. & 5 others, , 2021, In: Cancers. 13, 19, 4846.Research output: Contribution to journal › Journal article › Research › peer-review
- 2020
- Published
Treatment Algorithm for Advanced ALK-Rearranged NSCLC
Urbanska, E. M., Sørensen, Jens Benn & Santoni Rugiu, Eric, Sep 2020, In: Journal of Thoracic Oncology. 15, 9, p. e156-e157Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition
Urbanska, E. M., Sørensen, Jens Benn, Melchior, L. C., Costa, J. C. & Santoni Rugiu, Eric, 2020, In: International Journal of Molecular Sciences (Online). 21, 8, 12 p., 2847.Research output: Contribution to journal › Journal article › Research › peer-review
- 2019
- Published
Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.
Santoni Rugiu, Eric, Melchior, L. C., Urbanska, E. M., Jakobsen, J. N., Stricker, K. D., Grauslund, M. & Sørensen, Jens Benn, 1 Jul 2019, In: Cancers. 11, 7, 923.Research output: Contribution to journal › Review › Research › peer-review
- Published
18F-FDG PET/CT Findings in Disseminated Genital Herpes in an Immunocompetent Patient With Anaplastic Lymphoma Kinase Rearranged Advanced Nonsmall Cell Lung Cancer
Dejanovic, D., Amtoft, A. G., Sørensen, Jens Benn & Pøhl, M., 2019, In: Clinical Nuclear Medicine. 44, 5, p. e351-e352Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
Scagliotti, G. V., Gaafar, R., Nowak, A. K., Nakano, T., van Meerbeeck, J., Popat, S., Vogelzang, N. J., Grosso, F., Aboelhassan, R., Jakopovic, M., Ceresoli, G. L., Taylor, P., Orlandi, F., Fennell, D. A., Novello, S., Scherpereel, A., Kuribayashi, K., Cedres, S., Sørensen, J. B., Pavlakis, N. & 6 others, , 2019, In: The Lancet Respiratory Medicine. 7, 7, p. 569-580 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Very Early Response Evaluation by PET/MR in Patients with Lung Cancer: Timing and Feasibility
Langer, N. H., Langer, Seppo W., Johannesen, H. H., Hansen, A. E., Costa, J., Klausen, T. L., Forman, Julie Lyng, Olin, A., Rasmussen, S. H., Sørensen, Jens Benn, Löfgren, J., Kjær, A. & Fischer, B. M., 2019, In: Diagnostics. 9, 1, 13 p., 35.Research output: Contribution to journal › Journal article › Research › peer-review
- 2018
- Published
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
Buhl, I. K., Santoni Rugiu, Eric, Ravn, J., Hansen, A., Christensen, I. J., Jensen, T., Pratt, B., Askaa, J., Jensen, P. B., Knudsen, S. & Sørensen, Jens Benn, 22 Mar 2018, In: PLOS ONE. 13, 3, 18 p., e0194609.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Changing Resistance Mechanisms in Rebiopsies of ALK-Positive NSCLC During Multiple Lines of Therapy: ALK/BRAF-Mutations Followed By EMT
Urbanska, E., Melchior, L., De Stricker, K., Sørensen, Jens Benn & Rugiu, E. S., 2018, In: Journal of Thoracic Oncology. 13, 10, p. S946 1 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment
Jakobsen, J. N., Santoni Rugiu, Eric, Grauslund, M., Melchior, L. & Sørensen, Jens Benn, 2018, In: OncoTarget. 9, 40, p. 26195-26208Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
Gandhi, L., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., De Angelis, F., Domine, M., Clingan, P., Hochmair, M. J., Powell, S. F., Cheng, S. Y-S., Bischoff, H. G., Peled, N., Grossi, F., Jennens, R. R., Reck, M., Hui, R., Garon, E. B., Boyer, M., Rubio-Viqueira, B. & 19 others, , 2018, In: The New England Journal of Medicine. 378, 22, p. 2078-2092Research output: Contribution to journal › Journal article › Research › peer-review
- 2017
- Published
Concomitant Driver Mutations in Advanced Stage Non-Small-Cell Lung Cancer of Adenocarcinoma Subtype with Activating EGFR-Mutation
Sørensen, Jens Benn, Grauslund, M., Melchior, L., Jakobsen, J. N. & Santoni Rugiu, Eric, 2017, In: Journal of Thoracic Oncology. 12, S1, p. S518-S519Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Heterogeneous Resistance Mechanisms in Rebiopsies from EGFR-Mutated NSCLC: Transformation to SCLC; FGFR3 and T790M Mutations
Urbanska, E., Grauslund, M., Melchior, L., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2017, In: Journal of Thoracic Oncology. 12, 11 - S2, p. S2203Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation
Santoni Rugiu, Eric, Grauslund, M., Melchior, L. C., Costa, J. C., Sørensen, Jens Benn & Urbanska, E. M., 2017, In: Lung Cancer. 113, p. 14-17 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Implementation of lung cancer CT screening in the Nordic countries
Pedersen, J. H., Sørensen, Jens Benn, Saghir, Z., Fløtten, Ø., Brustugun, O. T., Ashraf, H., Strand, T., Friesland, S., Koyi, H., Ek, L., Nyrén, S., Bergman, P., Jekunen, A., Nieminen, E. & Gudbjartsson, T., 2017, In: Acta Oncologica. 56, 10, p. 1249-1257Research output: Contribution to journal › Review › Research › peer-review
- Published
Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial
Grosso, F., Steele, N., Novello, S., Nowak, A. K., Popat, S., Greillier, L., John, T., Leighl, N. B., Reck, M., Taylor, P., Planchard, D., Sørensen, Jens Benn, Socinski, M. A., von Wangenheim, U., Loembé, A. B., Barrueco, J., Morsli, N. & Scagliotti, G., 2017, In: Journal of Clinical Oncology. 35, 31, p. 3591-3600Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking
Skov, B. G., Clementsen, P., Larsen, Klaus Richter, Sørensen, Jens Benn & Mellemgaard, A., 2017, In: Histopathology. 70, 6, p. 889-895Research output: Contribution to journal › Journal article › Research › peer-review
- 2016
- Published
Prospective blinded evaluation predicting efficacy of adjuvant cisplatinum and vinorelbine by a multigene assay after radical surgery in non-small cell lung cancer
Buhl, I. K., Santoni Rugiu, Eric, Ravn, J., Hansen, A., Christensen, I. J., Jensen, T., Jensen, P. B., Askaa, J., Knudsen, S. & Sørensen, Jens Benn, 2016, In: Journal of Clinical Oncology. e20007.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- 2015
- Published
High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural Mesothelioma
Zimling, Z. G., Santoni Rugiu, Eric, Bech, C. & Sørensen, Jens Benn, Dec 2015, In: Anticancer Research. 35, 12, p. 6731-8 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma
Andersen, M., Trapani, D., Ravn, J., Sørensen, Jens Benn, Andersen, C. B., Grauslund, M. & Santoni Rugiu, Eric, Nov 2015, In: Anticancer Research. 35, 11, p. 6223-9 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Long-term Oncologic and Financial Implications of Lung Cancer Screening
Pedersen, J. J. H. & Sørensen, Jens Benn, May 2015, In: Thoracic Surgery Clinics. 25, 2, p. 223-9 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population
Skov, B. G., Høgdall, E., Clementsen, P., Krasnik, M., Larsen, Klaus Richter, Sørensen, Jens Benn, Skov, T. & Mellemgaard, A., Feb 2015, In: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 123, 2, p. 108-115 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma
Andersen, Morten, Trapani, D., Ravn, J., Sørensen, Jens Benn, Andersen, C. B., Grauslund, M. & Santoni Rugiu, Eric, 2015, In: Anticancer Research.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Use of TUBB3 for patient stratification and prognosis in lung cancer
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2015, In: Lung Cancer Management.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Use of next Generation Sequencing to Distinguish Origin of Poorly Differentiated Carcinomas in the Lung from Carcinomas in Other Organs
Sørensen, Jens Benn, Grauslund, M., Melchior, L., Urbanska, E. & Santoni Rugiu, Eric, 2015, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Versatile multigene expression biomarker for predicting clinical platinum sensitivity in non-small cell lung cancer (NSCLC) and ovarian cancer (OC)
Buhl, I. K., Christensen, I. J., Hansen, A., Jensen, T., Buhl, U. H., Brunner, N., Madsen, M. W., Sørensen, Jens Benn, Ravn, J., Santoni Rugiu, Eric, Askaa, J., Jensen, P. B. & Knudsen, S., 2015, In: Journal of Clinical Oncology. 33, 15, Supplement, e18502.Research output: Contribution to journal › Journal article › Research › peer-review
- 2014
- Published
Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma
Andersen, M., Grauslund, M., Ravn, J., Sørensen, Jens Benn, Andersen, C. B. & Santoni Rugiu, Eric, Jul 2014, In: The Journal of molecular diagnostics : JMD. 16, 4, p. 418-430 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Insulin-like Growth Factor Receptor 1 mRNA Expression as a Prognostic Marker in Advanced Non-small Cell Lung Cancer
Vilmar, A., Santoni Rugiu, Eric, Cillas, J. G., Huarriz, M. & Sørensen, Jens Benn, Jun 2014, In: Anticancer Research. 34, 6, p. 2991-2996 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, Apr 2014, In: Journal of Cancer Research and Clinical Oncology. 140, 4, p. 645-652 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, Feb 2014, In: Histopathology. 64, 3, p. 412-420 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, Jan 2014, In: Cancer Chemotherapy and Pharmacology. 73, 1, p. 131-137 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, Jan 2014, In: Cancer Chemotherapy and Pharmacology. 73, 1, p. 43-51 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2013
- Published
Clinical impact of ki-67 labeling index in non-small cell lung cancer
Jakobsen, J. N. & Sørensen, Jens Benn, 2013, In: Lung Cancer. 79, 1, p. 1-7 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report
Rossing, H. H., Grauslund, M., Urbanska, E. M., Melchior, L. C., Rask, C., Costa, J. C., Skov, B. G., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2013, In: BMC Research Notes. 6, December, p. 1-8 8 p., 489.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Diagnostic potential of microRNAs (miRs) in malignant pleural mesothelioma (MPM)
Andersen, Morten, Grauslund, M., Ravn, J., Sørensen, Jens Benn, Andersen, C. B. & Santoni Rugiu, Eric, 2013, In: Cancer Research.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
INTRATUMOR VARIATION OF BIOMARKER EXPRESSION BY IMMUNOHISTOCHEMISTRY IN RESECTABLE NON-SMALL CELL LUNG CANCER
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
IS RRM1 A PREDICTIVE MARKER FOR VINORELBINE EFFICACY - THE RESULTS FROM A COHORT OF MALIGNANT PLEURAL MESOTHELIOMAS TREATED WITH CISPLATIN AND VINORELBINE
Zimling, Z. G., Santoni Rugiu, Eric, Bech, C. & Sørensen, Jens Benn, 2013, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer
Jakobsen, J. N., Santoni Rugiu, Eric, Ravn, J. & Sørensen, Jens Benn, 2013, In: European journal of cancer (Oxford, England : 1990). 49, 11, p. 2494-2503 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PRETREATMENT THYMIDYLATE SYNTHASE PROTEIN EXPRESSION LEVELS REMAINS STABLE DURING PACLITAXEL AND CARBOPLATIN TREATMENT IN NON-SMALL CELL LUNG CANCER
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC)
Nørøxe, D. S., Wallerek, S. & Sørensen, Jens Benn, 2013, In: Anticancer Research. 33, 8, p. 3275-3278 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial
Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 24, 2, p. 309-14 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
RRM1 protein expression heterogeneity between diagnostic biopsies and resection specimens and changes in expression during carboplatin and paclitaxel treatment in non-small cell lung cancer
Jakobsen, J., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: European Journal of Cancer.Research output: Contribution to journal › Journal article › Research › peer-review
- 2012
- Published
A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma
Zimling, Z. G., Sørensen, Jens Benn, Gerds, Thomas Alexander, Bech, C., Andersen, C. B. & Santoni Rugiu, Eric, Nov 2012, In: Cancer Chemotherapy and Pharmacology. 70, 5, p. 743-54 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity
Jensen, S. A. & Sørensen, Jens Benn, 2012, In: Cancer Chemotherapy and Pharmacology. 69, 1, p. 57-64 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant plural mesothelioma
Zimling, Z. G., Sørensen, Jens Benn, Gerds, Thomas Alexander, Bech, C., Andersen, C. B. & Santoni-Rugiu, E., 2012, In: Cancer Chemotherapy and Pharmacology. 70, 5, p. 743-754 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?
Andersen, M., Grauslund, M., Muhammad-Ali, M., Ravn, J., Sørensen, Jens Benn, Andersen, C. B. & Santoni Rugiu, Eric, 2012, In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 120, 9, p. 767-9 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
Knudsen, M. G. & Sørensen, Jens Benn, 2012, In: Lung Cancer. 76, 2, p. 138-43 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer
Jakobsen, J. N. & Sørensen, Jens Benn, 2012, In: Cancer Chemotherapy and Pharmacology. 69, 2, p. 289-99 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival
Zimling, Z. G., Sørensen, Jens Benn, Gerds, Thomas Alexander, Bech, C., Andersen, C. B. & Santoni Rugiu, Eric, 2012, In: Journal of Thoracic Oncology. 7, 1, p. 249-56 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PROGNOSTIC AND PREDICTIVE IMPACT OF KI-67 INDEX IN NEO-ADJUVANT CHEMOTHERAPY BEFORE SURGERY IN NON-SMALL CELL LUNG CANCER
Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2012, In: Annals of Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomized in a chemotherapy phase III trial
Vilmar, A., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2012, In: Journal of Clinical Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC
Vilmar, A. C., Garcia-Foncillas, J., Huarriz, M., Santoni Rugiu, Eric, Sørensen, Jens Benn & Vilmar, A. C., 2012, In: Lung Cancer. 75, 3, p. 306-12 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Second-line Oral Vinorelbine Following First-Line Platinum and Pemetrexed in Malignant Pleural Mesothelioma
Sørensen, Jens Benn, Langer, S. W., Urbanska, E. & Aamdal, E., 2012, In: European Journal of Clinical & Medical Oncology. 4, 4, p. 1-7Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas
Olsen, I. M. H., Sørensen, Jens Benn, Federspiel, B., Kjær, Andreas, Hansen, C. P., Knigge, Ulrich & Langer, S. W., 2012, In: Scientific World Journal. 2012, p. 170496 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Ultra-late relapse with a single cerebellar metastasis 10 years after complete surgery for stage IIA non-small cell lung cancer (bronchioalveolar carcinoma)
Nørøxe, D. S. & Sørensen, Jens Benn, 2012, In: Journal of Thoracic Oncology. 7, 4, p. 764-5 2 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2011
- Published
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010
Felip, E., Gridelli, C., Baas, P., Rosell, R., Stahel, R., Sørensen, Jens Benn & Panel Members, P. M., Jul 2011, In: Annals of Oncology. 22, 7, p. 1507-19 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Pharmacokinetic evaluation of pemetrexed
Sørensen, Jens Benn, Jul 2011, In: Expert Opinion on Drug Metabolism & Toxicology. 7, 7, p. 919-28 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Review on clinical trials of targeted treatments in malignant mesothelioma
Jakobsen, J. N. & Sørensen, Jens Benn, Jul 2011, In: Cancer Chemotherapy and Pharmacology. 68, 1, p. 1-15 15 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Vilmar, A. C. & Sørensen, Jens Benn, Mar 2011, In: European Respiratory Journal. 20, 119, p. 45-52 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer
Stahel, R., Thatcher, N., Früh, M., Le Péchoux, C., Postmus, P. E., Sørensen, Jens Benn, Felip, E. & Panel members, P. M., 2011, In: Annals of Oncology. 22, 9, p. 1973-80 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
AN IMMUNOHISTOCHEMICAL PROFILE FOR PREDICTING RESPONSE TO CISPLATIN/VINORELBINE THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA
Zimling, Z. G., Bech, C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
CLASS III beta-TUBULIN, HISTOPATHOLOGY AND QUALITY OF LIFE IN ADVANCED NSCLC PATIENTS RANDOMIZED IN A LARGE MULTICENTER PHASE III TRIAL
Vilmar, A., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Class III beta-Tubulin in Advanced NSCLC of Adenocarcinoma Subtype Predicts Superior Outcome in a Randomized Trial
Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Clinical Cancer Research.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial
Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Clinical Cancer Research. 17, 15, p. 5205-14 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunohistochemical detection of ERCC1 and class III beta-tubulin in 54 malignant pleural mesotheliomas treated with cisplatin and vinorelbine: association with treatment response and survival
Zimling, Z. G., Bech, C., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2011, In: APMIS.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin
Afzal, Shoaib, Jensen, S. A., Sørensen, Jens Benn, Henriksen, T., Weimann, A. & Poulsen, Henrik Enghusen, 2011, In: Cancer Chemotherapy and Pharmacology. 69, p. 301-307Research output: Contribution to journal › Journal article › Research › peer-review
- Published
RT-PCR VERSUS IMMUNOHISTOCHEMISTRY FOR CORRELATION AND QUANTIFICATION OF ERCC1, BRCA1, TUBB3 & RRM1 IN NSCLC
Vilmar, A., Garcia-Focillas, J., Huarriz, M., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2011, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- 2010
- Published
Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle
Jensen, S. A., Hasbak, P., Mortensen, Jann & Sørensen, Jens Benn, 20 Dec 2010, In: Journal of Clinical Oncology. 28, 36, p. 5280-6 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome
Jensen, S. A., Vainer, B., Bartels, A., Brünner, N. A. & Sørensen, Jens Benn, 1 Dec 2010, In: European Journal of Cancer. 46, 18, p. 3233-42 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Diagnostik af malignt pleuralt mesoteliom
Sørensen, Jens Benn, 27 Sep 2010, In: Ugeskrift for Laeger. 172, 39, p. 2669Research output: Contribution to journal › Journal article › Research › peer-review
- Published
ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial
Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 1 Sep 2010, In: Annals of Oncology. 21, 9, p. 1817-24 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial
Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 1 Jun 2010, In: European Journal of Cancer. 46, 9, p. 1554-62 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Pemetrexed safety and pharmacokinetics in patients with third-space fluid
Dickgreber, N. J., Sørensen, Jens Benn, Paz-Ares, L. G., Schytte, T. K., Latz, J. E., Schneck, K. B., Zheng, Y. & Sanchez-Torres, J. M., 15 May 2010, In: Clinical Cancer Research. 16, 10, p. 2872-80 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Chemotherapy induced pathologic complete response in malignant pleural mesothelioma: a review and case report
Bech, C. & Sørensen, Jens Benn, 1 May 2010, In: Journal of Thoracic Oncology. 5, 5, p. 735-40 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)
Stahel, R., Baas, P., Faivre-Finn, C., Dooms, C., Passlick, B., Mazières, J., Cappuzzo, F., Früh, M., Sørensen, Jens Benn, Blackhall, F., Taron, M., Gridelli, C., O'Byrne, K. & Rosell, R., 1 Apr 2010, In: Lung Cancer. 68, 1, p. 121-4 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Hjertepåvirkning fra 5-fluorouracil og capecitabin
Jensen, S. A., Jensen, L. B., Petersen, L. N., Reiter, L. & Sørensen, Jens Benn, 4 Jan 2010, In: Ugeskrift for Laeger. 172, 1, p. 48-51 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome
Jensen, S. A., Vainer, B., Bartels, Annette Snejbjerg, Brünner, N. & Sørensen, Jens Benn, 2010, In: European journal of cancer (Oxford, England : 1990). 46, 18, p. 3233-42 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunohistochemical Detection of Erccl and Class III beta-tubulin in 54 Malignant Pleural Mesotheliomas Treated With Cisplatin and Vinorelbine: Association With Treatment Response and Survival
Zimling, Z. G., Bech, C., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2010, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Impact of the excision repair cross-complementation group 1 predictive biomarker on toxicity and quality of life in advanced non-small cell lung cancer patients randomized in a large, multicenter, cisplatin-based phase III trial
Santoni Rugiu, Eric, Vilmar, A. & Sørensen, Jens Benn, 2010, In: Virchows Archiv.Research output: Contribution to journal › Journal article › Research › peer-review
- 2009
- Published
Bisphosphonate use in patients with lung cancer and bone metastases: recommendations of a European expert panel
De Marinis, F., Eberhardt, W., Harper, P. G., Sureda, B. M., Nackaerts, K., Sørensen, Jens Benn, Syrigos, K. & Trédaniel, J., 2009, In: Journal of Thoracic Oncology. 4, 10, p. 1280-8 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression
Jensen, S. A., Vainer, B., Kruhøffer, M. & Sørensen, Jens Benn, 2009, In: BMC Cancer. 9, p. 25Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Screening for asbestbetingede sygdomme?
Brauer, C., Baandrup, U., Jacobsen, P., Krasnik, M., Olsen, J. H., Pedersen, J. H., Rasmussen, T. R., Schlünssen, V., Sherson, D., Svolgaard, B., Sørensen, Jens Benn & Omland, O., 2009, In: Ugeskrift for læger. 171, 6, p. 433-6 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effect of n-3-fatty acids on quality of life in patients with lung cancer
Møller, G., Nørgaard, M., Dannerfjord, S. H., Lauritzen, Lotte, Sørensen, Jens Benn, Lange, P., Jensen, N. A., Boisen, L. W., Jensen, Ramon Gordon, Andersen, M. & Andersen, Jens Rikardt, 2009, 18. årsmøde i klinisk ernæring: Århus, 2009. p. 25 1 p.Research output: Chapter in Book/Report/Conference proceeding › Conference abstract in proceedings › Research
- Published
The effect of n-3-fatty acids on quality of life in patients with lung cancer
Møller, G., Nørgaard, M., Dannerfjord, S. H., Lauritzen, Lotte, Sørensen, Jens Benn, Lange, Peter, Jensen, N., Boisen, L. W., Jensen, R. G., Andersen, M. & Andersen, Jens Rikardt, 2009, In: Journal of Parenteral and Enteral Nutrition. 33, 2, p. 215 1 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- 2008
- Published
Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
Frank, H., Palshof, T. & Sørensen, Jens Benn, 2008, In: British Journal of Cancer. 99, 1, p. 44-50 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Current concepts in chemotherapy for malignant pleural mesothelioma
Sorensen, J. B. & Sørensen, Jens Benn, 2008, In: Clinical Respiratory Journal. 2, p. 74-79 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies
Skovsgaard, T., Bork, E., Damstrup, L., Ingeberg, S. & Sørensen, Jens Benn, 2008, In: Cancer. 112, 7, p. 1600-1606 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Exercise on prescription: a randomized study on the effect of counseling vs counseling and supervised exercise
Kragstrup, J., Skovgaard, T., Puggaard, L. & Sørensen, Jens Benn, 2008, In: Scandinavian Journal of Medicine & Science in Sports. 18, 3, p. 288-297 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Outpatient management of febrile neutropenia: time to revise the present treatment strategy
Carstensen, M. & Sørensen, Jens Benn, 2008, In: Journal of Supportive Oncology. 6, 5, p. 199-208 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome
Bech, C. & Sørensen, Jens Benn, 2008, In: Journal of Thoracic Oncology. 3, 11, p. 1359-1360 1 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer
Jensen, S. A., Vainer, B., Witton, C. J., Jørgensen, J. T. & Sørensen, Jens Benn, 2008, In: Acta Oncologica. 47, 6, p. 1054-1061 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Third-line therapy for metastatic colorectal cancer
Gundgaard, M. G., Ehrnrooth, E. & Sørensen, Jens Benn, 2008, In: Cancer Chemotherapy and Pharmacology. 61, 1, p. 1-13 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study
Hillerdal, G., Sundstrom, S., Riska, H., Vikstrom, A., Hjerpe, A. & Sørensen, Jens Benn, 2008, In: Journal of Thoracic Oncology. 3, 11, p. 1325-1331 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic study
Hillerdal, G., Sundstrom, S., Vikstrom, A., Hjerpe, A. & Sørensen, Jens Benn, 2008, In: Clinical Respiratory Journal. 3, p. 80-85 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 1996
- Published
Brain relapses in chemotherapy-treated small cell lung cancer: A retrospective review of two time-dose regimens of therapeutic brain irradiation
Bach, F., Sørensen, Jens Benn, Adrian, L., Larsen, H., Langer, Seppo W., Nelausen, K. M. & Engelholm, S. A., Sep 1996, In: Lung Cancer. 15, 2, p. 171-181 11 p.Research output: Contribution to journal › Review › Research › peer-review
ID: 34406177
Most downloads
-
162
downloads
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
99
downloads
Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
72
downloads
Very Early Response Evaluation by PET/MR in Patients with Lung Cancer: Timing and Feasibility
Research output: Contribution to journal › Journal article › Research › peer-review
Published